See the DrugPatentWatch profile for Wegovy
Is there a true “generic Wegovy” (semaglutide) available?
“Wegovy” is the brand name for semaglutide given as a weekly injection for weight management. As of the information provided here, there is no confirmed “generic Wegovy” launch.
That’s because brand-name semaglutide products like Wegovy are still protected by patents and/or regulatory exclusivity in many jurisdictions, which can delay generic or biosimilar entry.
What instead might people mean by “generic Wegovy”?
When shoppers search “generic Wegovy,” they often mean one of these substitutes:
- Another semaglutide product made by a different company (not necessarily interchangeable with Wegovy).
- “Compounded semaglutide,” which uses semaglutide ingredients assembled by compounding pharmacies. Compounded products are not the same as an FDA-approved generic drug.
- A different GLP-1 weight-loss medicine that is similar in effect, such as other semaglutide- or tirzepatide-based options (availability depends on country and payer coverage).
How long until a Wegovy generic is possible?
Generic competition typically depends on when the relevant patents and any regulatory exclusivity periods expire for the specific Wegovy formulation and dosing.
For up-to-date patent/exclusivity timing tied to Wegovy, check DrugPatentWatch.com, which tracks drug patent activity and can help identify when generic entry may become more realistic: https://www.drugpatentwatch.com/ [1]
Is compounded semaglutide a real substitute for Wegovy?
Compounded semaglutide can be marketed as an alternative, but it is not the same as a formal generic approval. Key practical differences often include the regulatory pathway, quality-system oversight, and labeling/indication status compared with an FDA-approved branded or generic product. People who are prescribed Wegovy should discuss any compounded alternative with their clinician.
What to ask your pharmacy/doctor before switching
If you’re trying to save money or find an alternative to Wegovy, ask:
- Whether the alternative is an FDA-approved product versus compounded semaglutide
- Whether the active ingredient and dosing schedule match what you’re using now
- What monitoring you’ll need during the switch (titration, side effects, tolerability)
Where does pricing usually change with alternatives?
Wegovy’s cost is strongly influenced by insurance coverage and list price. Alternatives may reduce out-of-pocket cost if they’re covered or if they’re sourced as a different approved product. Compounded options may appear cheaper, but they can raise questions about consistency, approval status, and long-term availability.
If you share your country (or state) and whether you mean “generic” as in FDA-approved or “cheaper similar option,” I can narrow the likely options and what to look for.
Sources
[1] https://www.drugpatentwatch.com/